Johnson Non Current Liabilities Total vs Total Liab Analysis
JNJ Stock | USD 155.17 0.33 0.21% |
Johnson Johnson financial indicator trend analysis is infinitely more than just investigating Johnson Johnson recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Johnson Johnson is a good investment. Please check the relationship between Johnson Johnson Non Current Liabilities Total and its Total Liab accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Johnson Johnson. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Johnson Stock please use our How to buy in Johnson Stock guide.
Non Current Liabilities Total vs Total Liab
Non Current Liabilities Total vs Total Liab Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Johnson Johnson Non Current Liabilities Total account and Total Liab. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Johnson Johnson's Non Current Liabilities Total and Total Liab is 0.96. Overlapping area represents the amount of variation of Non Current Liabilities Total that can explain the historical movement of Total Liab in the same time period over historical financial statements of Johnson Johnson, assuming nothing else is changed. The correlation between historical values of Johnson Johnson's Non Current Liabilities Total and Total Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Liabilities Total of Johnson Johnson are associated (or correlated) with its Total Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liab has no effect on the direction of Non Current Liabilities Total i.e., Johnson Johnson's Non Current Liabilities Total and Total Liab go up and down completely randomly.
Correlation Coefficient | 0.96 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Non Current Liabilities Total
Total Liab
The total amount of all liabilities that a company has, including both short-term and long-term liabilities.Most indicators from Johnson Johnson's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Johnson Johnson current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Johnson Johnson. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Johnson Stock please use our How to buy in Johnson Stock guide.At this time, Johnson Johnson's Tax Provision is relatively stable compared to the past year. Issuance Of Capital Stock is expected to hike to about 4.5 B this year, although Enterprise Value Multiple will most likely fall to 10.10.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 55.3B | 55.4B | 58.4B | 34.3B | Total Revenue | 78.7B | 80.0B | 85.2B | 49.3B |
Johnson Johnson fundamental ratios Correlations
Click cells to compare fundamentals
Johnson Johnson Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Johnson Johnson fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 157.7B | 174.9B | 182.0B | 187.4B | 167.6B | 175.9B | |
Short Long Term Debt Total | 27.7B | 35.3B | 33.8B | 39.6B | 29.3B | 30.8B | |
Other Current Liab | 26.2B | 29.0B | 29.3B | 30.9B | 30.2B | 31.7B | |
Total Current Liabilities | 36.0B | 42.5B | 45.2B | 55.8B | 46.3B | 48.6B | |
Total Stockholder Equity | 59.5B | 63.3B | 74.0B | 76.8B | 68.8B | 38.7B | |
Property Plant And Equipment Net | 17.7B | 18.8B | 19.0B | 18.0B | 19.9B | 11.6B | |
Net Debt | 10.4B | 21.3B | 19.3B | 26.8B | 7.5B | 7.8B | |
Retained Earnings | 110.7B | 113.9B | 123.1B | 128.3B | 153.8B | 161.5B | |
Cash | 17.3B | 14.0B | 14.5B | 12.9B | 21.9B | 23.0B | |
Non Current Assets Total | 112.5B | 123.7B | 121.0B | 132.1B | 114.1B | 119.8B | |
Non Currrent Assets Other | 4.5B | 6.6B | 10.2B | 30.6B | 5.1B | 3.4B | |
Cash And Short Term Investments | 19.3B | 25.2B | 31.6B | 22.3B | 22.9B | 14.3B | |
Net Receivables | 14.5B | 13.6B | 15.3B | 14.0B | 14.9B | 8.0B | |
Common Stock Shares Outstanding | 2.7B | 2.7B | 2.7B | 2.7B | 2.6B | 2.2B | |
Liabilities And Stockholders Equity | 157.7B | 174.9B | 182.0B | 187.4B | 167.6B | 175.9B | |
Non Current Liabilities Total | 62.3B | 69.1B | 62.8B | 54.8B | 52.5B | 55.1B | |
Inventory | 9.0B | 9.3B | 10.4B | 10.3B | 11.2B | 11.7B | |
Other Current Assets | 2.5B | 3.1B | 3.7B | 8.7B | 4.5B | 3.5B | |
Other Stockholder Equity | (38.4B) | (38.5B) | (39.1B) | (41.7B) | (75.7B) | (71.9B) | |
Total Liab | 98.3B | 111.6B | 108.0B | 110.6B | 98.8B | 103.7B | |
Total Current Assets | 45.3B | 51.2B | 61.0B | 55.3B | 53.5B | 31.1B | |
Short Term Debt | 1.2B | 2.6B | 3.8B | 12.8B | 3.5B | 3.0B | |
Intangible Assets | 47.6B | 53.4B | 46.4B | 38.5B | 34.2B | 18.7B | |
Accounts Payable | 8.5B | 9.5B | 11.1B | 9.9B | 9.6B | 5.4B | |
Short Term Investments | 2.0B | 11.2B | 17.1B | 9.4B | 1.1B | 1.0B | |
Property Plant And Equipment Gross | 18.6B | 18.8B | 47.7B | 49.3B | 47.8B | 50.2B | |
Accumulated Other Comprehensive Income | (15.9B) | (15.2B) | (13.1B) | (13.0B) | (12.5B) | (11.9B) | |
Other Liab | 35.1B | 35.4B | 31.8B | 26.6B | 30.6B | 18.8B | |
Other Assets | 11.4B | 3.9B | 17.2B | 17.0B | 19.6B | 20.6B | |
Long Term Debt | 26.5B | 32.6B | 30.0B | 26.9B | 25.9B | 15.4B | |
Good Will | 33.6B | 36.4B | 35.2B | 36.0B | 36.6B | 21.5B | |
Treasury Stock | (38.4B) | (38.5B) | (39.1B) | (41.7B) | (75.7B) | (71.9B) | |
Property Plant Equipment | 17.7B | 18.8B | 19.0B | 19.8B | 22.8B | 15.8B | |
Current Deferred Revenue | 1.9B | 7.6B | 7.8B | 3.0B | 3.4B | 4.5B | |
Net Tangible Assets | (21.8B) | (26.5B) | (13.1B) | (16.8B) | (15.1B) | (14.3B) | |
Retained Earnings Total Equity | 110.7B | 113.9B | 123.1B | 128.3B | 147.6B | 110.0B |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Johnson Johnson. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Johnson Stock please use our How to buy in Johnson Stock guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Johnson Johnson. If investors know Johnson will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Johnson Johnson listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.89) | Dividend Share 4.86 | Earnings Share 6.05 | Revenue Per Share 36.428 | Quarterly Revenue Growth 0.052 |
The market value of Johnson Johnson is measured differently than its book value, which is the value of Johnson that is recorded on the company's balance sheet. Investors also form their own opinion of Johnson Johnson's value that differs from its market value or its book value, called intrinsic value, which is Johnson Johnson's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Johnson Johnson's market value can be influenced by many factors that don't directly affect Johnson Johnson's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Johnson Johnson's value and its price as these two are different measures arrived at by different means. Investors typically determine if Johnson Johnson is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Johnson Johnson's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.